ID

22692

Beschreibung

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

Stichworte

Versionen (1)
  1. 09.06.17 09.06.17 -
Rechteinhaber

Genentech, Inc.

Hochgeladen am

9. Juni 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

FOLLOW-UP CONTACT DAY 0 CRFs Roche FVF4170G Macular Edema NCT00473382

Englisch

FOLLOW-UP CONTACT DAY 0 CRFs Roche FVF4170G Macular Edema NCT00473382

1 Formulare  
Patient administration
Beschreibung

Patient administration

Subject Number
Beschreibung

PT

Datentyp

integer

Alias
UMLS CUI [1]
C2348585
Subject Initials:
Beschreibung

PTINIT

Datentyp

text

Alias
UMLS CUI [1,1]
C1997894
UMLS CUI [1,2]
C2986440
Report Date:
Beschreibung

VDT

Datentyp

date

Alias
UMLS CUI [1,1]
C1302584
FOLLOW-UP CONTACT (DAY 0)
Beschreibung

FOLLOW-UP CONTACT (DAY 0)

Was the subject contacted 2-4 days after study treatment?
Beschreibung

CONTACT [CONTAC]

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1705415
UMLS CUI [1,2]
C2709088
Date of Contact:
Beschreibung

CONTACT_DT [CONDT]

Datentyp

date

Maßeinheiten
  • DD/MMM/YY
Alias
UMLS CUI [1,1]
C1705415
UMLS CUI [1,2]
C0011008
DD/MMM/YY
Has the subject been taking the prescribed self-administered post-injection antimicrobials?
Beschreibung

Note: If Yes was answered to any of the questions below, the subject should return as soon as possible to the clinic for a safety assessment. Record on AE or SAE CRF if appropriate.

Datentyp

boolean

Alias
UMLS CUI [1]
C0338237
Decrease in Vision: Has the subject experienced a decrease in vision in the study eye since treatment?
Beschreibung

VISION_DECREASED [VSNDEC]

Datentyp

boolean

Alias
UMLS CUI [1]
C4280600
Eye Pain: Has the subject had any eye pain in the study eye since treatment?
Beschreibung

EYE_PAIN [EYEPN]

Datentyp

boolean

Alias
UMLS CUI [1]
C0151827
Unusual Redness: Has the subject had any new or unusual redness in the study eye (other than localized redness at the injection site) since treatment?
Beschreibung

EYE_REDNESS [EYERED]

Datentyp

boolean

Alias
UMLS CUI [1]
C0235267
New Ocular Symptoms: Has the subject experienced any other new ocular symptoms in the study eye since treatment?
Beschreibung

NEW_SYMPTOM [NEWSX]

Datentyp

boolean

Alias
UMLS CUI [1]
C0586406
Safety Assessment Visit: Was the subject asked to return to the clinic for a safety assessment visit?
Beschreibung

ASSESSMENT_DONE [ASMTDN]

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0589121
UMLS CUI [1,2]
C0549076
Zum Seitenanfang zurückkehren

Ähnliche Modelle

FOLLOW-UP CONTACT DAY 0 CRFs Roche FVF4170G Macular Edema NCT00473382

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Patient administration
PT
Item
Subject Number
integer
C2348585 (UMLS CUI [1])
PTINIT
Item
Subject Initials:
text
C1997894 (UMLS CUI [1,1])
C2986440 (UMLS CUI [1,2])
VDT
Item
Report Date:
date
C1302584 (UMLS CUI [1,1])
Item Group
FOLLOW-UP CONTACT (DAY 0)
CONTACT [CONTAC]
Item
Was the subject contacted 2-4 days after study treatment?
boolean
C1705415 (UMLS CUI [1,1])
C2709088 (UMLS CUI [1,2])
CONTACT_DT [CONDT]
Item
Date of Contact:
date
C1705415 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
ANTIBIOTICS_CURRENT [ABXCR]
Item
Has the subject been taking the prescribed self-administered post-injection antimicrobials?
boolean
C0338237 (UMLS CUI [1])
VISION_DECREASED [VSNDEC]
Item
Decrease in Vision: Has the subject experienced a decrease in vision in the study eye since treatment?
boolean
C4280600 (UMLS CUI [1])
EYE_PAIN [EYEPN]
Item
Eye Pain: Has the subject had any eye pain in the study eye since treatment?
boolean
C0151827 (UMLS CUI [1])
EYE_REDNESS [EYERED]
Item
Unusual Redness: Has the subject had any new or unusual redness in the study eye (other than localized redness at the injection site) since treatment?
boolean
C0235267 (UMLS CUI [1])
NEW_SYMPTOM [NEWSX]
Item
New Ocular Symptoms: Has the subject experienced any other new ocular symptoms in the study eye since treatment?
boolean
C0586406 (UMLS CUI [1])
ASSESSMENT_DONE [ASMTDN]
Item
Safety Assessment Visit: Was the subject asked to return to the clinic for a safety assessment visit?
boolean
C0589121 (UMLS CUI [1,1])
C0549076 (UMLS CUI [1,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video